Literature DB >> 19282309

ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health.

A Boonen1, J Braun, I E van der Horst Bruinsma, F Huang, W Maksymowych, N Kostanjsek, A Cieza, G Stucki, D van der Heijde.   

Abstract

OBJECTIVE: To report on the results of a standardised consensus process agreeing on concepts typical and/or relevant when classifying functioning and health in patients with ankylosing spondylitis (AS) based on the International Classification of Functioning and Health (ICF).
METHODS: Experts in AS from different professional and geographical backgrounds attended a consensus conference and were divided into three working groups. Rheumatologists were selected from members of the Assessment of SpondyloArthritis international Society (ASAS). Other health professionals were recommended by ASAS members. The aim was to compose three working groups with five to seven participants to allow everybody's contribution in the discussions. Experts selected ICF categories that were considered typical and/or relevant for AS during a standardised consensus process by integrating evidence from preceding studies in alternating working group and plenary discussions. A Comprehensive ICF Core Set was selected for the comprehensive classification of functioning and a Brief ICF Core Set for application in trials.
RESULTS: The conference was attended by 19 experts from 12 countries. Eighty categories were included in the Comprehensive Core Set, which included 23 Body functions, 19 Body structures, 24 Activities and participation and 14 Environmental factors. Nineteen categories were selected for the Brief Core Set, which included 6 Body functions, 4 Body structures, 7 Activities and participation and 2 Environmental factors.
CONCLUSION: The Comprehensive and Brief ICF Core Sets for AS are now available and aim to represent the external reference to define consequences of AS on functioning.

Entities:  

Mesh:

Year:  2010        PMID: 19282309     DOI: 10.1136/ard.2008.104117

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

Review 1.  Measuring outcomes in adult spinal deformity surgery: a systematic review to identify current strengths, weaknesses and gaps in patient-reported outcome measures.

Authors:  Sayf S A Faraj; Miranda L van Hooff; Roderick M Holewijn; David W Polly; Tsjitske M Haanstra; Marinus de Kleuver
Journal:  Eur Spine J       Date:  2017-05-22       Impact factor: 3.134

2.  [ASAS/EULAR recommendations for the management of ankylosing spondylitis : evaluation of the 2010 update in the German-speaking area].

Authors:  U Kiltz; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2013-02       Impact factor: 1.372

3.  Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health Index.

Authors:  Marco Di Carlo; Valentina Lato; Andrea Di Matteo; Marina Carotti; Fausto Salaffi
Journal:  Rheumatol Int       Date:  2017-01-06       Impact factor: 2.631

4.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 9 International classification of functioning, disability and health (ICF)].

Authors:  U Kiltz; W Mau; U Repschläger; E Böhle; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

5.  Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF).

Authors:  Eveline M Kool; Marieke J Nijsten; Annelies E van Ede; Tim L Jansen; William J Taylor
Journal:  Clin Rheumatol       Date:  2016-06-14       Impact factor: 2.980

Review 6.  State-of-the-art: outcome assessment in adult spinal deformity.

Authors:  Jeffrey L Gum; Leah Y Carreon; Steven D Glassman
Journal:  Spine Deform       Date:  2020-10-09

Review 7.  [Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].

Authors:  U Kiltz; M Rudwaleit; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

8.  Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.

Authors:  U Kiltz; D van der Heijde; A Boonen; A Cieza; G Stucki; M A Khan; W P Maksymowych; H Marzo-Ortega; J Reveille; S Stebbings; C Bostan; J Braun
Journal:  Ann Rheum Dis       Date:  2014-01-07       Impact factor: 19.103

Review 9.  Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?

Authors:  Andrew Keat; Alexander N Bennett; Karl Gaffney; Helena Marzo-Ortega; Raj Sengupta; Tamara Everiss
Journal:  Rheumatol Int       Date:  2016-12-29       Impact factor: 2.631

10.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.